These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4373396)

  • 21. Persistent Newcastle disease virus infection in embryonic chicken tracheal organ cultures.
    Cummiskey JF; Hallum JV; Skinner MS; Leslie GA
    Infect Immun; 1973 Oct; 8(4):657-64. PubMed ID: 4355139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Phenomenon of tolerance (hyporeactivity) in interferonogenesis].
    Solov'ev VD; Balandin IG; Marchenko VI; Diuĭsalieva RG; Kol'tsov VD
    Vopr Virusol; 1974; (2):156-61. PubMed ID: 4374823
    [No Abstract]   [Full Text] [Related]  

  • 23. Hyporeactivity factor produced after induction of immune interferon in mice sensitized with BCG.
    Minagawa T; Ho M
    Infect Immun; 1978 Nov; 22(2):371-7. PubMed ID: 365756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine leukemia: depressed response to interferon induction correlated with a serum hyporeactive factor.
    Stringfellow DA
    Infect Immun; 1976 Feb; 13(2):392-8. PubMed ID: 177366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of interferon in human diploid cell cultures.
    Zielińska-Jenczylik J; Rzucidlo Z; Sypula A; Blach-Olszewska Z; Kidankiewicz T
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):769-75. PubMed ID: 187142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterospecific activity of rat interferon.
    Lobodzińska M; Mejbaum-Katzenellenbogen W; Biernacka I; Zamorska B; Albin M; Skurska Z
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):493-7. PubMed ID: 219806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative aspects of interferon-induced plaque reduction: kinetics of interferon action.
    Jordan GW
    Virology; 1972 May; 48(2):425-32. PubMed ID: 4337029
    [No Abstract]   [Full Text] [Related]  

  • 28. Interferon-hyporesponsiveness in mice in connection with dose interval and site of administration of Newcastle disease virus. Reflexion in serum complement levels.
    Rathová V; Kocisková D; Borecký L
    Acta Virol; 1975 Apr; 19(2):158-61. PubMed ID: 239563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of vesicular stomatitis virus infection on the histocompatibility antigen of L cells.
    Hecht TT; Summers DF
    J Virol; 1972 Oct; 10(4):578-85. PubMed ID: 4343540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiviral activity of murine interferons produced by bacterial and animal cell translation of messenger RNA].
    Mamontova TV; Mentkevich LM; Orlova TG
    Vopr Virusol; 1980; (1):63-7. PubMed ID: 6158177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to virus infection during the hyporeactive state of interferon induction.
    Sharpe TJ; Birch PJ; Planterose DN
    J Gen Virol; 1971 Sep; 12(3):331-3. PubMed ID: 4330349
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro cellular immunity to unrelated pathogens in chickens infected with fowlpox virus.
    Pathak PN; Rao GV; Tompkins WA
    Infect Immun; 1974 Jul; 10(1):34-41. PubMed ID: 4366915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cortisol on interferon production by mouse peritoneal leukocytes and spleen in vitro and in vivo.
    Mendelson J; Finland M
    Proc Soc Exp Biol Med; 1966 Oct; 123(1):98-104. PubMed ID: 4288628
    [No Abstract]   [Full Text] [Related]  

  • 34. Age-related cellular resistance of the chicken embryo to viral infections. I. Interferon and natural resistance to myxoviruses and vesicular stomatitis virus.
    Morahan PS; Grossberg SE
    J Infect Dis; 1970 Jun; 121(6):615-23. PubMed ID: 4316147
    [No Abstract]   [Full Text] [Related]  

  • 35. Interferon induction by viruses. XIII. Detection and assay of interferon induction-suppressing particles.
    Marcus PI; Sekellick MJ
    Virology; 1985 Apr; 142(2):411-5. PubMed ID: 2414906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of exogenous interferon on virus-specific immune cytolysis].
    Ovsiannikova NV; Karmysheva VIa
    Vopr Virusol; 1980; (1):72-6. PubMed ID: 6158178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virus vaccine and passive immunization for the prevention of viral myocarditis in mice.
    Matsumori A; Crumpacker CS; Abelmann WH; Kawai C
    Jpn Circ J; 1987 Dec; 51(12):1362-4. PubMed ID: 2832629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of antilymphocytic serum on circulating interferon in mice as a function of the inducer.
    de Maeyer-Guignard J; de Maeyer E
    Nat New Biol; 1971 Feb; 229(7):212-4. PubMed ID: 4325471
    [No Abstract]   [Full Text] [Related]  

  • 39. Mode of action and biological properties of insoluble interferon.
    Chany C; Ankel H; Galliot B; Chevalier MJ; Gregoire A
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):293-9. PubMed ID: 4373752
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mouse macrophage interferons].
    Mentkevich LM; Churbakova EV
    Vopr Virusol; 1981; (4):410-4. PubMed ID: 6171097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.